Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C β-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial
| Autor: | Vinik, Aaron I., Bril, Vera, Kempler, Peter, Litchy, William J., Tesfaye, Solomon, Price, Karen L., Bastyr, Edward J., III |
|---|---|
| Zdroj: | In Clinical Therapeutics 2005 27(8):1164-1180 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect